NOVATEC LIGHTBLADE LASER ENTERING CLINICAL TRIAL FOR PARK
This article was originally published in The Gray Sheet
Executive Summary
NOVATEC LIGHTBLADE LASER ENTERING CLINICAL TRIAL FOR PARK in the next few weeks, the company says. Novatec Laser Systems was granted an investigational device exemption to start treating patients suffering low to moderate myopia using the solid-state surface laser. The study will involve five to ten patients at the Manhattan Eye, Ear and Throat Hospital in New York City and should be completed in three to six months, according to the company.